Clinical Trials Browser

Phase 4 × Completed × Prednisone × Clear all

NCT05457257 2025-12-19

Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations

Phase 4 Completed

43 enrolled 16 charts

Metastatic Castration-resistant Prostate Cancer

NCT01995513 2023-09-18

PLATO

Phase 4 Completed

509 enrolled 18 charts

Prostatic Neoplasms

NCT02485691 2022-05-27

CARD

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

NCT00853008 2020-04-07

LAL-AR/2003

Phase 4 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02074137 2016-06-02

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Phase 4 Completed

Prostate Cancer Metastatic

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

Phase 4 Completed

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01358253 2014-05-20

Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia

Phase 4 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00494897 2009-05-19

PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Phase 4 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma